Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
deals
3
×
life sciences
national blog main
new york blog main
san diego blog main
san francisco blog main
3
×
boston blog main
cancer
cancer diagnostics
merck
national top stories
raleigh-durham blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
10x genomics
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
armo biosciences
arvinas
astellas pharma
autoimmune
avalon ventures
batten disease
bayer
becton dickinson
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer immunotherapy
What
company
3
×
acquisitions
adding
advance
aims
albert
biggest
bio
biology
bourla
ceo
crispr
cytokine
deal
decisions
diagnostic
diagnostics
drug
drugs
enhanced
expand
files
fold
future
help
imports
initial
ipo
laying
make
maker
maps
measured
money
nanostring
offering
patients
pfizer
pfizer’s
physicians
Language
unknown
unset
Current search:
company
×
deals
×
photo
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs